Streptavidin-ZAP conjugated to biotinylated Chlorotoxin [97] (CTX-SAP) was used to selectively target Matrix Metallopeptidase 2 (MMP-2), which is known to be expressed by ML-1 thyroid cancer cells. This evidence concerns the gene MMP2 and thyroid gland carcinoma.